Loading...
Successful erlotinib rechallenge after both gefitinib- and erlotinib-induced interstitial lung diseases
Epidermal growth factor receptor tyrosine kinase inhibitors, gefitnib and erlotinib, are effective for advanced nonsmall-cell lung cancer with epidermal growth factor receptor gene mutation. However, interstitial lung disease induced by these drugs is sometimes fatal, and discontinuation of the medi...
Na minha lista:
| Main Authors: | , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Blackwell Publishing Ltd
2013
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4184641/ https://ncbi.nlm.nih.gov/pubmed/25473530 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/rcr2.12 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|